跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,284 条关于
“Scienture, LLC”
全部
3,284
临床试验
527
药物
459
机构
1,696
资讯
602
去年
FDA Approves First Liquid Losartan Formulation for Hypertension Treatment
去年
Scienture Launches REZENOPY, Most Potent Naloxone Nasal Spray for Opioid Overdose Treatment
去年
Scienture Secures FDA Orange Book Patent Listing for ARBLI™ Losartan Potassium Oral Suspension
4个月前
Scienture Secures Third Patent for ARBLI Losartan Oral Suspension, Extending Market Exclusivity Through 2041
去年
Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues
9个月前
Scienture Secures Patent Protection for REZENOPY, Highest-Strength Naloxone Nasal Spray Ahead of Q2 2026 Launch
去年
MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases
去年
Scienture's Arbli Becomes First FDA-Approved Ready-to-Use Liquid Losartan, Securing Major Market Access
7年前
FDA Rejects Mallinckrodt's Abuse-Deterrent Roxicodone Reformulation
昨天
Otsuka ICU Medical Recalls One Lot of 0.9% Sodium Chloride Injection After Potassium Chloride Mix-Up
第 1 页,共 61 页
上一页
下一页